Global Live Attenuated Vaccines Information, By Type (Bacterial, Viral), Vaccine Development (Tissue Culture, Embryonated Eggs, Live Animals), And End Users (Hospitals, Clinics, Diagnostic Centers, Research Institute, Others) - Forecast Till 2023
Global Live Attenuated Vaccines Market – Overview
A variety of vaccines are available in the market to train the immune system how to fight off certain kinds of germs and the serious diseases they cause. The developmental procedure of vaccines depends upon various factors including immune system responds to the antigen, type of vaccination needed, cost of manufacturing. Thus, based on methodology and technique, vaccine is classified into live-attenuated vaccines, inactivated vaccines subunit, recombinant, polysaccharide, and conjugate vaccines, and toxoid vaccines. Live vaccines when have weakened (attenuated) form of the antigen, then it is referred to as attenuated vaccine. The advantage associated with such vaccines is inclusive of natural infection mechanism leading to strong and long-lasting immune response. Factors such as increasing awareness about vaccination, growing government funding for vaccination programs and increasing prevalence of infectious diseases drive the growth of this market. The developing economies of the Asia Pacific like India has the largest number of births in the world, i.e., more than 26 million per year. According to the United Nations Children's Emergency Fund, ~ 20% of the total child mortality across the globe are reported in India.
Thus, the Indian government is aiming to provide immunization to the children, to improve health and raise life expectancy of the infants. For instance, it is reported that nine million routine immunization (RI) sessions are organized in India each year. Moreover, economies like China within the region are witnessing an increase in the investment support for vaccination. Gavi is estimated to invest USD 800,000 from 2001-2022 in the form of Vaccine Introduction Grant (VIG) for China. Moreover, improving healthcare infrastructure, increasing demand for LAV, and emphasis on prevention of diseases also drives this market. However, factors such as limited efficiency and high cost of development are the majors factors estimated to restraint the market growth during the forecast period.
Global Live Attenuated Vaccines Market is projected to reach USD 45.2 billion by 2023 from USD 34.2 billion in 2016 with an approximate CAGR of 10.7% from 2017 to 2023.
Top Players List:
GlaxoSmithKline, plc. (U.K.), Merck & Co. (U.S.), Pfizer, Inc. (U.S.), Astellas Pharma Inc. (Japan), Johnson & Johnson (U.S.), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), MedImmune, LLC (U.S.), Sanofi (France), and Serum Institute of India Pvt. Ltd. (India). and others are some of the prominent players at the forefront of competition in the Global Live Attenuated Vaccines Market and are profiled in MRFR Analysis.
Segments:
The market for Blood Glucose Test Strip market is segmented on the basis of Technology which includes sub segments like Thick Film Electrochemical, Thin Film Electrochemical and Optical.
Global Live Attenuated Vaccines Market - Regional Analysis
The Americas leads the live attenuated vaccine market. Factors such as increasing healthcare infrastructure and increasing government support are the major drivers for the market within the region.
Followed by the Americas, Europe holds the second largest market, owing to the huge presence of prominent players and well-developed healthcare infrastructure. Moreover, the presence of development economies like the Germany, France, Italy, and others along with research and development provides suitable backgrounds for the market to grow.
Asia Pacific is the fastest growing market due to the presence of countries like India, China, and others. Such developing economies have high potential of generating business for market players. Followed by the Asia Pacific region, the Middle East & Africa holds the lowest share of the market. Most of the countries within this region are low income countries with low per capita healthcare expenditure, and stringent government policies. In the Middle East & African region. The Middle Eastern region in the Middle East & Africa is estimated to lead the market due the presence of developed economies like Saudi Arabia, Kuwait, Dubai, Qatar, and others within the regional boundaries.
Get Full Report at https://www.marketresearchfuture.com/reports/live-attenuated-vaccines-market-1101
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment